What is APYX's current stock price?

APYX is currently trading at $3.63 with a daily change of +0.28%. Visit StocksRunner for live updates.

What are APYX stock's key strengths?

APYX current strengths include: Earnings are forecast to grow, Upgraded on attractively valued. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with APYX stock?

Current risk factors for APYX include: Extreme. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is APYX's current StocksRunner IQ Score?

APYX current StocksRunner IQ Score is: Hold. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence APYX's StocksRunner IQ Score?

APYX StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

APYX Stock Analysis & IQ Rating | Apyx Medical Corporation

Q: Should I buy APYX stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for APYX aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Hold. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for APYX?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in APYX near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

APYX

Apyx Medical Corporation

$3.63

+$0.01 | +0.28%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$4.5

MKT CAP

$151.84M

52W Low

$0.83

VOL

$124.50K

P/E Ratio

N/A

AVG VOL

$127.49K

RSI

49.45

TREND

Downtrend

APYX Stock IQ

Login to see Apyx Medical Corporation (APYX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

APYX Target Price

Login to display

Strengths

APYX Rewards

Upgraded on attractively valued

APYX Rewards

Earnings are forecast to grow

APYX Price Performance

$3.84 (-5.47%)

$3.71 (-2.16%)

$3.13 (+15.97%)

$1.37 (+164.96%)

1year

6month

3month

1month

APYX Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

APYX Analysts opinion is positive and it remained unchanged from the past 3 months

APYX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%

Consensus Rating

100%

Buy
Opinion

100%

Trend
Score

100%

Potential
Score

APYX Street Sentiment is extremely bullish and have positive views on the near-term outlook

APYX Risk Level

APYX has Extreme risk level

Risk Indicators

Beta greater than 1.0

Price under $5

Low volume

Extreme

LOW

HIGH

APYX Performance Sentiment

Sentiments overview associated with events and the stock performance

100%

Positive

10 out of 10
events present

0%

Negative

0 out of 10
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

N/A

Resistance Price

$3.72

Current Price Range

$3.53

N/A

$3.72

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Consensus Rating

STRONG BUY

3

Buy

0

Hold

0

Sell

Date

Action

Rating

Firm

Mar 12, 2026

Upgrade

Buy

BTIG

Mar 11, 2026

Upgrade

Outperform

Mizuho

Dec 17, 2025

Initiate

Buy

Roth

APYX Latest Analysis +

BTIG Upgrades Apyx Medical (APYX). Fintel reports that on March 11 2026 BTIG upgraded their outlook for Apyx Medical (NasdaqGS:APYX) from Neutral to Buy. Analyst Price Forecast Suggests 48.48% Upside

Thu Mar 12, 2026

$3.62 | -7.89%

Rating

Apyx Medical Corp Q4 And FY25 Revenue Improves. Lifts FY26 Revenue View By Approx. 9%-10%. Stock Up . (RTTNews) - Apyx Medical Corp. (APYX) a surgical aesthetics company specialising in electrosurgical equipment and medical devices reported a narrower net loss in the financial results for its fourth quarter and full year ended 2025 driven by revenue growth. In addition the fi

Thu Mar 12, 2026

$3.62 | -7.89%

Activity

Momentum

This JM Smucker Analyst Turns ish. Here Are Top 4 Upgrades For Wednesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.Mizuho analyst Uy Ear upgraded Uniqure NV (NASDAQ:QURE) from Neutral to Outperform and raised the price target from $12 to $35. uniQure shares closed at $18.26 on Tuesday. See how other analysts view this stock.BTIG analyst Sam

Wed Mar 11, 2026

$3.93 | +13.91%

Rating

Apyx Medical outlines 9%–11% revenue growth target for 2026 as AYON launch accelerates.

Tue Mar 10, 2026

$3.45 | +0.58%

Potential

Earnings call transcript: Apyx Medical Q4 2025 revenue beats forecast stock rises.

Tue Mar 10, 2026

$3.45 | +0.58%

Earnings

Apyx Medical GAAP EPS of -$0.03 beats by $0.03 revenue of $19.16M beats by $0.04M.

Tue Mar 10, 2026

$3.45 | +0.58%

Earnings

A Preview Of Apyx Medicals Earnings. Apyx Medical (NASDAQ:APYX) will release its quarterly earnings report on Tuesday 2026-03-10. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate Apyx Medical to report an earnings per share (EPS) of $-0.06.The market awaits Apyx Medical'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand that guidance can

Mon Mar 9, 2026

$3.43 | +9.94%

Earnings

FAQ About APYX Stock Insights

What is APYX current stock price?

What are APYX stock strengths?

What is APYX Risk Level?

What is APYX market cap and volume?

What is APYX current Stock IQ?

Should I buy APYX stock right now?

Is APYX a Strong Buy right now?

What does a 'Strong Buy' rating mean for APYX?

What does a 'Strong Sell' rating mean for APYX?

What factors influence APYX's Stock IQ?

Explore our APYX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored APYX Stock Strategies
Effective Risk Management

FIND US ON

Receive our APYX Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

APYX

Apyx Medical Corporation

Set Alerts

Current Price

$3.63

+$0.01 | +0.28%

52W High

$4.5

MKT CAP

$151.84M

52W Low

$0.83

VOL

$124.50K

P/E Ratio

N/A

AVG VOL

$127.49K

RSI

49.45

TREND

Downtrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

APYX Price Performance

$3.84 (-5.47%)

$3.71 (-2.16%)

$3.13 (+15.97%)

$1.37 (+164.96%)

1year

6month

3month

1month

APYX Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

APYX Analysts opinion is positive and it remained unchanged from the past 3 months